Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|95|4|452-456

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.95, Iss.4, 2015-0, pp. : 452-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlation of gleason scores with magnetic resonance diffusion tensor imaging in peripheral zone prostate cancer

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 2, 2015-08 ,pp. : 460-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

By  

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1034-1042

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Gleason Scores from Sextant Prostate Biopsies and Radical Prostatectomy Specimens

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 14-18

Karger

Access to resources Recommend Favorite

Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3992-4002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gleason Score 6 - Prostate Cancer or Benign Variant?

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 629-632

Karger

Access to resources Recommend Favorite